Company Hwail Pharmaceutical Co.,Ltd.

Equities

A061250

KR7061250007

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-05-16 EDT 5-day change 1st Jan Change
1,647 KRW +0.73% Intraday chart for Hwail Pharmaceutical Co.,Ltd. +1.17% -25.31%

Business Summary

HWAIL PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceutical raw materials. The Company produces aceclofenac, lornoxicam, triflusal, dicloalphenazone, gallamine triethyl iodide, acemetacin, levosulpiride, alibendol, erdostein, talniflumate, topiramate, phloroglucin, oxatomide and others used as expectorants, cough remedies, antispasmodics, analgesics, anti-inflammatories and others under the brand name EDST, TRPR, LVSP, ACCL and others. It also provides finished formulations, including injection products such as ceftazidime, cefoperazone, cefotaxime, cefaclor, cefatrizine, cefroxadine and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 130

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Ingredients
100.0 %
- - 122,541 100.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.1 %
132,053 100.0 % 121,409 99.1 % -8.06%
Overseas
0.9 %
-- 1,133 0.9 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 63 79-04-30
Chief Executive Officer 75 13-09-30
Chief Tech/Sci/R&D Officer 72 10-01-31
Director/Board Member 61 13-09-30
Sales & Marketing 55 13-11-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 75 13-09-30
Chief Executive Officer 63 79-04-30
Director/Board Member 61 13-09-30
Director/Board Member 54 14-03-20
Director/Board Member 69 13-10-13
Director/Board Member 65 17-03-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,877,652 37,494,853 ( 48.77 %) 0 48.77 %

Shareholders

NameEquities%Valuation
17,696,218 26.60 % 21 M ₩
6,217,663 9.345 % 7 M ₩
4,876,847 7.330 % 6 M ₩
3,791,240 5.698 % 4 M ₩
2,340,000 3.517 % 3 M ₩
Hwail Pharmaceutical Co., Ltd. Employee Stock Ownership Asso.
1.816 %
1,208,323 1.816 % 1 M ₩
Dimensional Fund Advisors Ltd.
0.0743 %
49,414 0.0743 % 57 526 ₩
DFA Australia Ltd.
0.003144 %
2,092 0.003144 % 2 435 ₩

Holdings

NameEquities%Valuation
831,203 7.28% 3,770,811 $
2,340,000 3.52% 2,724,158 $

Company contact information

HWAIL PHARMACEUTICAL Co., Ltd.

57 Jeyakgongdan 3-gil Hyangnam-eup

18622, Hwaseong

+

http://www.hwail.com
address Hwail Pharmaceutical Co.,Ltd.(A061250)
  1. Stock Market
  2. Equities
  3. A061250 Stock
  4. Company Hwail Pharmaceutical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW